HyQvia^® provides protection from infection and is the only monthly* subQ IG infusion.

Q: Who should not take HYQVIA?

Do not take HYQVIA if you: Are allergic to IgG, hyaluronidase, other blood products, or any ingredient in HYQVIA.

Q: What should I avoid while taking HYQVIA?

HYQVIA can make vaccines (like measles/mumps/rubella or chickenpox vaccines) not work as well for you. Before you get any vaccines, tell your HCP that you take HYQVIA.

Q: What should I tell my HCP before I start using or while using HYQVIA?

Tell your HCP if you: Have or had any kidney, liver, or heart problems or history of blood clots because HYQVIA can make these problems worse. Have IgA deficiency or a history of severe allergic reactions to IgG or other blood products. Are pregnant, trying to become pregnant or are breast feeding. It is not known whether HYQVIA can harm the unborn baby or breastfed infant.

If you’re discovering HyQvia for the first time, coming from another therapy, welcome. Here, you'll learn about monthly* infusions with HyQvia and how you could have more time between infusions for things you enjoy.

*Every 3 or 4 weeks.

Why HyQvia? Find out!

*Every 3 or 4 weeks.

Bye, frequent infusions and Hy, more beach day between infusions inside of two speech bubbles.

In a clinical study, Patients experienced 0.025 acute serious bacterial infections (ASBIs) per patient year. Here’s what that means:

HyQvia was studied in a clinical trial of 83 patients with primary immunodeficiency (PI), with the main goal of measuring how many ASBIs they experienced over the course of 1 year.

ASBIs are short-term but serious infections caused by bacteria that require immediate medical care. The FDA standard for efficacy—that is, if an immunoglobulin works—is less than 1 ASBI per year. In the clinical trial, people taking HyQvia experienced significantly less than that.

ASBIs included 2 cases of pneumonia that occurred during the 12 months after ramp-up (P<0.0001; upper 99% confidence limit, 0.046)
Both cases of pneumonia received outpatient treatment with oral antibiotics. During the ramp-up period, there was an additional case of pneumonia that required hospitalization

Tell me more

In a clinical study, Patients infusing HyQvia experienced 52% reduction of general (systemic) side effects (like fatigue and headache) compared to those on IVIG infusions.

The number of these general (systemic) side effects was 222 per 1,129 HyQvia infusions (a rate of 0.20) vs 154 per 365 IVIG infusions (a rate of 0.42).

The most common general (systemic) side effects were headache, antibody formation against hyaluronidase (Hy), fatigue, nausea, fever, and vomiting.

In people using HyQvia, the most common side effects at the infusion site (local) were pain, redness, swelling, and itching.

Read on

Find safety information here.

This is where you’ll find important safety info, including the warning about blood clots, to consider when starting and monitoring your treatment with HyQvia and to discuss with your doctor.

See safety info

You may be eligible for a co-pay assistance program that covers up to 100% of treatment costs if you’re eligible.

Great! How?

We only send the kind of emails you want to read.

Sign up for HyQvia emails to learn more and get relevant, helpful info sent straight to you. We're happy to share.

Yes, please

IMPORTANT SAFETY INFORMATION and serious warnings regarding blood clots

What is HYQVIA?

HYQVIA is a liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.

IMPORTANT SAFETY INFORMATION

What is the most important information that I should know about HYQVIA?

HYQVIA can cause blood clots.
Call your healthcare professional (HCP) if you have pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s), unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, numbness or weakness on one side of the body.
Your HCP may perform blood tests regularly to check your IgG level.
Do not infuse HYQVIA into or around an infected or red swollen area because it can cause infection to spread.

Who should not take HYQVIA?

Do not take HYQVIA if you:

Are allergic to IgG, hyaluronidase, other blood products, or any ingredient in HYQVIA.

What should I avoid while taking HYQVIA?

HYQVIA can make vaccines (like measles/mumps/rubella or chickenpox vaccines) not work as well for you. Before you get any vaccines, tell your HCP that you take HYQVIA.

What should I tell my HCP before I start using or while using HYQVIA?

Tell your HCP if you:

Have or had any kidney, liver, or heart problems or history of blood clots because HYQVIA can make these problems worse.
Have IgA deficiency or a history of severe allergic reactions to IgG or other blood products.
Are pregnant, trying to become pregnant or are breast feeding. It is not known whether HYQVIA can harm the unborn baby or breastfed infant.

What are the possible or reasonably likely side effects of HYQVIA?

HYQVIA can cause serious side effects. If any of the following problems occur after starting HYQVIA, stop the infusion immediately and contact your HCP or call emergency services:

Hives, swelling in the mouth or throat, itching, trouble breathing, wheezing, fainting or dizziness. These could be signs of a serious allergic reaction.
Bad headache with nausea, vomiting, stiff neck, fever, and sensitivity to light. These could be signs of irritation and swelling of the lining around your brain.
Reduced urination, sudden weight gain, or swelling in your legs. These could be signs of a kidney problem.
Pain, swelling, warmth, redness, or a lump in your legs or arms, other than at the infusion site(s). These could be signs of a blood clot.
Brown or red urine, fast heart rate, yellow skin or eyes. These could be signs of a liver or blood problem.
Chest pain or trouble breathing, blue lips or extremities. These could be signs of a serious heart or lung problem.
Fever over 100°F. This could be a sign of an infection.

After HYQVIA infusion a temporary, soft swelling may occur around the infusion site, which may last 1 to 3 days, due to the volume of fluid infused. The following possible side effects may occur at the site of infusion and generally go away within a few hours, and are less likely after the first few infusions.

Mild or moderate pain
Redness
Swelling
Itching

The most common side effects of HYQVIA are:

Headache
Fatigue
Nausea
Fever
Vomiting

Antibodies to the hyaluronidase component of HYQVIA were formed in some patients taking HYQVIA. It is not known if there is any long-term effect. In theory, these antibodies could react with your body’s own hyaluronidase (PH20). PH20 is present in the male reproductive tract. So far, these antibodies have not been associated with increased or new side-effects.

These are not all the possible side effects. Talk to your HCP about any side effect that bothers you or that does not go away.

For additional safety information, click for Information For Patients and discuss with your HCP.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.